| Apply targeted agents, immunotherapy and novel technologies to treat CNS tumors. |
|
|
|
|
|
| Properly manage brain metastases with systemic therapies. |
|
|
|
|
|
| Identify molecular/genetic factors in various CNS tumors. |
|
|
|
|
|
| Effectively utilize interventional and therapeutic options in the treatment of spinal tumors. |
|
|
|
|
|
| Identify uncommon CNS tumors, such as craniopharyngioma, H3K27M midline glioma and NF-associated tumors, based on novel actionable pathways. |
|
|
|
|
|
| Recognize the burden and trajectory of cognitive issues following therapy and potential interventions. |
|
|
|
|
|
